Collateral damage
Nat Biotechnol
.
2014 Jan;32(1):66-8.
doi: 10.1038/nbt.2779.
Author
Robert E W Hancock
1
Affiliation
1
Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada, and the Wellcome Trust Sanger Institute, Hinxton, UK.
PMID:
24406933
DOI:
10.1038/nbt.2779
No abstract available
Publication types
News
Comment
MeSH terms
Anti-Bacterial Agents / pharmacology*
Drug Design*
Drug Resistance, Bacterial / drug effects*
Humans
Substances
Anti-Bacterial Agents